Defending Nader is hard but I have always had that soft

New Post Public Reply Private Reply Replies (3) Message Board
Goosebumps Riztheinvestor #105409
1,090
Defending Nader is hard but I have always had that soft spot for Nader. I feel Nader is a genuinely good guy with a big heart and wants to badly get us an approval. I feel that he has based his whole life on this next approval of any kind… be it a EUA or equivalent. He can’t wait for it to happen. He NEEDS this validation personally. There would be no more dedication from any person that could or would replace him. We have a man with the upmost dedication in the right position at the right time.

I remember Nader saying after an approval he would take a limited roll and step down. My guess is just a BOD position as we search for that CEO that can build our company into a pharmaceutical company. A top CEO that has been there and knows how to grow our company into the largest pharmaceutical company we can become. This is my dream… as investors we have dreams… this is the top dream for return on our money.

Nader set us up for success with the partnership of Biomm and the CRO in Albert Einstein hospitals performing our trials. Nader has done his job. We now wait for results. Will we have mistakes at this point going forward? I don’t believe we will because Cytodyn is in a just watching mode. We wait and watch and reap the benefit of our current partnerships in Brazil. Biomm will take the Albert Einstein trial information and analyze it to death. Remember they had 20 people on each conference call while they developed the protocol for these trials. Biomm is committed and will be our knight in shining armor. They will get us our first approval.

I have been flipping the magic 8 ball over and over asking the right questions and getting the right answers. “ It will happen “ is my favorite answer. lol. I wonder how many people that read this will even know about the magic 8 ball and it’s crystal ball like predicted answers? lol

I make light of this but in reality we are in the best position we have ever been in looking at an approval. We have an experienced pharmaceutical in Biomm that can get the job done. We have a great CRO finally that will get it done in a timely manner. We have all the cards lined up for success and it’s just a little bit of time before we get the satisfaction we all have been waiting for. If leronlimab shows as we expect it to… we don’t have any issues any longer. We have substantial revenue to fund the other trials and buy more Leronlimab. Our revenue will set us free to help the world. The dominos of success will start the long road of falling into place just as we expected it to. We will have achieved our first of many approvals.

#letsgoBiomm

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Greenlight Networks Invests $100 Million to Boost Connectivity

Updated Category News Views 336

Greenlight Networks Expands Fiber Internet Services Greenlight Networks, a prominent fiber-to-the-home internet provider, is set to expand its fiber services into a new area with a significant investment of $100 million. This expansion aims to enhance high-speed internet access for residents and small businesses, ushering in new opportunities for economic growth and...

Continue Reading
Analyzing Meta Platforms in the Competitive Media Landscape

Updated Category News Views 152

Understanding Meta Platforms in the Market In the rapidly evolving business environment, it’s crucial for investors to closely examine firms prior to making investment choices. This article will provide a detailed analysis of Meta Platforms (NASDAQ: META) within the context of its main rivals in the Interactive Media & Services sector. By reviewing essential financial...

Continue Reading
Insights into Early Redemptions of Bonds Issued by Jyske Realkredit

Updated Category News Views 156

Exploring Preliminary Data on Early Redemptions In light of recent financial insights, Jyske Realkredit has released preliminary data regarding early redemptions, specifically focusing on prepayments related to bonds. This intriguing announcement is intended for stakeholders and interested parties looking to understand the dynamics of the bond market. Understanding Early...

Continue Reading
Eltek Ltd. Reports Robust Growth in Latest Financial Quarter

Updated Category News Views 64

Eltek Ltd. Announces Strong Performance for Q3 2024 Eltek Ltd. (NASDAQ: ELTK), a world-leading manufacturer of advanced printed circuit board solutions, has recently reported remarkable financial results for its third quarter, demonstrating a meaningful surge in revenues and profits. The company’s commitment to innovative practices in the PCB sector is reflected in its...

Continue Reading
Anticipation Grows for Palantir's AI Conference Insights

Updated Category News Views 132

Excitement Grows for Palantir Technologies' AI Conference As Palantir Technologies prepares for its upcoming conference focused on artificial intelligence, industry experts are eagerly anticipating the insights that could come from this significant event. A key topic of discussion is the recent extension of Palantir's partnership with a major energy player. Strategic...

Continue Reading